Document:

Award Formula for 2008

 EXHIBIT 10.2 
 AWARD FORMULA FOR 2008 
 LEGGETT & PLATT, INCORPORATED 
 2004 KEY OFFICERS INCENTIVE PLAN 
 The 2004 Key
Officers Incentive Plan (“Plan”) provides cash awards to participants based on the Company’s operating results for the prior year. There are two award formulas under the Plan: one for Corporate participants and one for Profit
Center participants. Under both formulas, a participant’s award is calculated by applying the award formula to a percentage of the participant’s annual salary at the end of the year (the “target percentage”). The award
formula and each participant’s target percentage are determined by the Plan Committee no later than 90 days after the beginning of each year. 
 Participants in the Plan are executive officers of the Company. The Company has a separate Key Management Incentive Plan for other employees. Awards under the Key Management Incentive Plan are calculated in substantially the same manner as
awards under the Plan. Collectively, the two plans are referred to as the “Incentive Plans.” 
 Award Formula for Corporate
Participants 
 Awards for Corporate participants are calculated based on the Company’s Return on Net Assets (“RONA”). Certain
adjustments are made to Earnings Before Interest and Taxes (“EBIT”) and net asset amounts reported in the Company’s consolidated Financial Statements to determine Plan RONA. 
  

	 	•	 	 “Return” is equal to EBIT with addbacks for (i) awards under the Incentive Plans, (ii) additional stock matches under the
Company’s Executive Stock Unit Program and Stock Bonus Plan, and (iii) restructuring-related and asset impairment costs. 

  

	 	•	 	 “Net Assets” are total assets with the following adjustments: (i) deduction of cash and current liabilities, (ii) deduction or
addback of accumulated other comprehensive income (deduction if positive, addback if negative) reported in shareholder’s equity section of balance sheet, (iii) deduction of goodwill and (iv) quarterly averaging of all
calculations. 

  

	 	•	 	 Acquisitions are excluded from RONA calculations during the first two years after the acquisition date. 

 The Committee may reduce a participant’s award by up to 10%, based on its evaluation of the participant’s performance during the year. 
 When the Company achieves at least 16% RONA in a calendar year, the corporate payout percentage will begin at 50% and will follow the schedule below. Payout percentages
for returns that fall between whole RONA percentage points are adjusted proportionately. No awards are payable for a year when RONA falls below 16%. The payout is capped at 150%. 
  

				
	 CORPORATE PARTICIPANT
PAYOUT SCHEDULE
	 
	 RONA
	 	Payout %	 
	<16%	 	0	%
	16%	 	50	%
	17%	 	60	%
	18%	 	70	%
	19%	 	80	%
	20%	 	90	%
	21%	 	100	%
	22%	 	110	%
	23%	 	120	%
	24%	 	130	%
	25%	 	140	%
	26%	 	150	%

 The award is calculated by multiplying a participant’s salary, his target percentage, and the payout percentage. For
example, assume a participant’s salary is $250,000, his target percentage is 50% and the company achieved a 21% RONA for a 100% payout percentage. The participant’s award, assuming no discretionary reduction, would be $125,000 (250,000 x
50% x 100%). 
 Award Formula for Profit Center Participants 
 Profit Center participants in the Plan manage numerous operating locations. The Company sets an Incentive Earnings target and a Return on Capital Employed (“ROCE”) target for each operating location
every year. Profit Center awards are based on achievement of these targets at operations under the participant’s supervision. Incentive Earnings equals operating income, plus an addback of corporate allocations. ROCE is equal to the Incentive
Earnings of the operations under the participant’s supervision, divided by the sum of those operations’ fixed assets and working capital. 
 The
award may be reduced by up to 20% for certain key compliance shortcomings relating to internal audit issues, accounting errors, safety/OSHA ratings, and unremedied environmental problems occurring in those operations under the participant’s
supervision. 
 The Profit Center award is determined as follows: 
  

			
	 Incentive Earnings (budget achievement)
	  	50% of total award
	 ROCE
	  	50% of total award
	 Potential Compliance Deduction
	  	(20% of total award)

 The table below is used to determine the payout. Payout percentages for returns that fall between whole percentage
points are adjusted proportionately. No awards are payable for achievement below 80%. The payout is capped at 150%. The Committee has the discretion to reduce any participant’s award by up to 10%. 
  

				
	 PROFIT CENTER PARTICIPANT
PAYOUT SCHEDULE
	 
	 Achievement
	 	Payout	 
	<80%	 	0	%
	80%	 	60	%
	90%	 	80	%
	100%	 	100	%
	110%	 	120	%
	120%	 	140	%
	125%	 	150	%

 The award is calculated by multiplying a participant’s salary at year end, his target percentage, and the
weighted payout percentage for each portion of the award. For example, assume a participant in the Plan has a $250,000 salary and a 50% target percentage, and the participant manages locations that collectively achieved 90% of their Incentive
Earnings targets and 110% of their ROCE targets for the year. The Incentive Earnings portion of the participant’s award would be $50,000 ($250,000 x 50% x 50% x 80%), and the ROCE portion of the award would be $75,000 ($250,000 x 50% x 50% x
120%) for a total award of $125,000. If the operations under the participant’s supervision had an average 4% compliance deduction, this would reduce the final award payout to $120,000 ($125,000 – [$250,000 x 50% x 4%]).Form of Warrant

 Exhibit 4.4 
 THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY OTHER APPLICABLE SECURITIES LAWS AND HAVE BEEN ISSUED IN RELIANCE UPON AN
EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND SUCH OTHER SECURITIES LAWS. NEITHER THIS SECURITY NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED, HYPOTHECATED OR
OTHERWISE DISPOSED OF, EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO A TRANSACTION WHICH IS EXEMPT FROM, OR NOT SUBJECT TO, SUCH REGISTRATION, IN EACH CASE IN ACCORDANCE WITH ALL APPLICABLE SECURITIES
LAWS, AND IN THE CASE OF A TRANSACTION EXEMPT FROM, OR NOT SUBJECT TO, SUCH REGISTRATION, UNLESS THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO IT THAT SUCH TRANSACTION DOES NOT REQUIRE REGISTRATION UNDER THE SECURITIES
ACT AND SUCH OTHER APPLICABLE LAWS. 
  

					
	WARRANT NO.             	 		  	NUMBER OF SHARES:         
	DATE OF ISSUANCE: March [    ], 2008	  	(subject to adjustment)        

 WARRANT TO PURCHASE SHARES 
 OF COMMON STOCK OF 
 CORCEPT THERAPEUTICS INCORPORATED 
 This Warrant is issued to
[                    ], or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that
certain Securities Purchase Agreement, dated as of March 14, 2008, between Corcept Therapeutics Incorporated, a Delaware corporation (the “Company”), the Purchaser and certain other purchasers thereunder (the “Purchase
Agreement”) and is subject to the terms and conditions of the Purchase Agreement. 
 1. EXERCISE OF WARRANT. 
 (a) Method of Exercise. Subject to the terms and conditions herein set forth, upon surrender of this Warrant at the principal office of the Company
and upon payment of the Warrant Price (as defined below) by wire transfer to the Company or cashier’s check drawn on a United States bank made payable to the order of the Company, or exercise of the right to credit the Warrant Price against the
fair market value of the Warrant Stock (as defined below) at the time of exercise (the “Net Exercise Right”) pursuant to Section 1(b), the Purchaser is entitled to purchase from the Company, at any time after the date hereof
and on or before 5:00 p.m. New York City time on March 24, 2015 (the “Expiration Date”) (subject to earlier termination of this Warrant as set forth herein), up to
             shares (as adjusted from time to time pursuant to the provisions of this Warrant) of Common Stock (as defined below) of the Company (the “Warrant
Stock”), at a purchase price of $2.77 per share (the “Warrant Price”). 

 (b) Net Exercise Right. If the Company shall receive written notice from the Purchaser at the time
of exercise of this Warrant that the holder elects to exercise the Net Exercise Right, the Company shall deliver to such holder (without payment by the Purchaser of any exercise price in cash) that number of fully paid and nonassessable shares of
Common Stock, par value $0.001 per share, of the Company (“Common Stock”) equal to the quotient obtained by dividing (y) the value of this Warrant (or the specified portion thereof) on the date of exercise, which value shall be
determined by subtracting (1) the aggregate Warrant Price of the Warrant Stock (or the specified portion thereof) immediately prior to the exercise of this Warrant from (2) the Aggregate Fair Market Value (as defined below) of the Warrant
Stock (or the specified portion thereof) issuable upon exercise of this Warrant (or specified portion thereof) on the date of exercise by (z) the Fair Market Value (as defined below) of one share of Common Stock on the date of exercise. The
“Fair Market Value” of a share of Common Stock shall mean the last reported sale price and, if there are no sales, the last reported bid price, of the Common Stock on the business day prior to the date of exercise as reported by the
NASDAQ Capital Market or such other principal exchange or quotation system on which the Common Stock is then traded or, if the Common Stock is not publicly traded, the price determined in good faith by the Company’s Board of Directors. The
“Aggregate Fair Market Value” of the Warrant Stock shall be determined by multiplying the number of shares of Warrant Stock by the Fair Market Value of one share of Warrant Stock. 
 2. CERTAIN ADJUSTMENTS. 
 (a) Mergers or
Consolidations. If at any time after the date hereof there shall be a capital reorganization (other than a combination or subdivision of Warrant Stock otherwise provided for herein) (a “Reorganization”), or a merger or
consolidation of the Company with another corporation (other than a merger with another corporation in which the Company is a continuing corporation and which does not result in any reclassification or change of outstanding securities issuable upon
exercise of this Warrant or a merger effected exclusively for the purpose of changing the domicile of the Company) (a “Merger”), then, as a part of such Reorganization or Merger, lawful provision shall be made so that the Purchaser
shall thereafter be entitled to receive upon exercise of this Warrant, during the period specified in this Warrant and upon payment of the Warrant Price (unless the Purchaser has elected the Net Exercise Right), the number of shares of stock or
other securities or property of the Company or the successor corporation resulting from such Reorganization or Merger, to which a holder of the Common Stock deliverable upon exercise of this Warrant would have been entitled under the provisions of
the agreement in such Reorganization or Merger if this Warrant had been exercised immediately before that Reorganization or Merger. In any such case, appropriate adjustment (as determined in good faith by the Company’s Board of Directors) shall
be made in the application of the provisions of this Warrant with respect to the rights and interests of the Purchaser after the Reorganization or Merger to the end that the provisions of this Warrant (including adjustment of the Warrant Price then
in effect and the number of shares of Warrant Stock) shall be applicable after that event, as near as reasonably may be, in relation to any shares or other property deliverable after that event upon exercise of this Warrant. The above provisions of
this paragraph shall similarly apply to successive reorganizations, reclassifications, exchanges, liquidations, recapitalizations, changes, consolidations, mergers, sales, transfers or other dispositions, if any. 
  

 -2- 

 (b) Splits and Subdivisions; Dividends. In the event the Company should at any time, or from time
to time, fix a record date for the effectuation of a split or subdivision of the outstanding shares of Common Stock or the determination of the holders of Common Stock entitled to receive a dividend or other distribution payable in additional shares
of Common Stock or other securities or rights convertible into, or entitling the holder thereof to receive directly or indirectly, additional shares of Common Stock (hereinafter referred to as the “Common Stock Equivalents”) without
payment of any consideration by such holder for the additional shares of Common Stock or Common Stock Equivalents (including the additional shares of Common Stock issuable upon conversion or exercise thereof), then, as of such record date (or the
date of such distribution, split or subdivision if no record date is fixed), the per share Warrant Price shall be appropriately decreased and the number of shares of Warrant Stock shall be appropriately increased in proportion to such increase (or
potential increase) of outstanding shares. 
 (c) Combination of Shares. If the number of shares of Common Stock outstanding at any
time after the date hereof is decreased by a combination of the outstanding shares of Common Stock, the per share Warrant Price shall be appropriately increased and the number of shares of Warrant Stock shall be appropriately decreased in proportion
to such decrease in outstanding shares. 
 (d) Adjustments for Other Distributions. In the event the Company shall declare a
distribution payable in securities of other persons, evidences of indebtedness issued by the Company or other persons, assets (excluding cash dividends paid out of net profits) or options or rights not referred to in Section 2(b), then, in each
such case for the purpose of this Section 2(d), upon exercise of this Warrant the holder hereof shall be entitled to a proportionate share of any such distribution as though such holder was the holder of the number of shares of Common Stock
into which this Warrant may be exercised as of the record date fixed for the determination of the holders of Common Stock entitled to receive such distribution. 
 3. NO FRACTIONAL SHARES. No fractional shares of Warrant Stock will be issued in connection with any exercise of this Warrant. In lieu of any fractional shares which would otherwise be issuable, the Company shall pay
cash equal to the product of such fraction multiplied by the Fair Market Value of one share of Warrant Stock. 
 4. NO STOCKHOLDER RIGHTS.
Until the exercise of this Warrant or any portion of this Warrant, the Purchaser shall not have nor exercise any rights by virtue hereof as a stockholder of the Company (including without limitation the right to notification of stockholder meetings
or the right to receive any notice or other communication concerning the business and affairs of the Company). 
 5. RESERVATION OF STOCK.
The Company covenants that during the period this Warrant is exercisable, the Company will reserve from its authorized and unissued Common Stock a sufficient number of shares of Common Stock (or other securities, if applicable) to provide for the
issuance of Warrant Stock (or other securities) upon the exercise of this Warrant. The Company agrees that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of executing stock certificates to
execute and issue the necessary certificates for the Warrant Stock upon the exercise of this Warrant. 
  

 -3- 

 6. MECHANICS OF EXERCISE. This Warrant may be exercised by the holder hereof, in whole or in part, by the
surrender of this Warrant and the Notice of Exercise attached hereto as Exhibit A duly completed and executed on behalf of the holder hereof, at the principal office of the Company together with payment in full of the Warrant Price (unless
the Purchaser has elected the Net Exercise Right) then in effect with respect to the number of shares of Warrant Stock as to which the Warrant is being exercised. This Warrant shall be deemed to have been exercised immediately prior to the close of
business on the date of its surrender for exercise as provided above, and the person entitled to receive the Warrant Stock issuable upon such exercise shall be treated for all purposes as the holder of such shares of record as of the close of
business on such date. As promptly as practicable on or after such date, the Company at its expense shall cause to be issued and delivered to the person or persons entitled to receive the same a certificate or certificates for the number of full
shares of Warrant Stock issuable upon such exercise, together with cash in lieu of any fraction of a share as provided above. The shares of Warrant Stock issuable upon exercise hereof shall, upon their issuance, be validly issued, fully paid and
nonassessable, and free from all preemptive rights, taxes, liens and charges with respect to the issue thereof. In the event that this Warrant is exercised in part, the Company at its expense will execute and deliver a new Warrant of like tenor
exercisable for the number of shares for which this Warrant may then be exercised. 
 7. CERTIFICATE OF ADJUSTMENT. Whenever the Warrant
Price or number or type of securities issuable upon exercise of this Warrant is adjusted, as herein provided, the Company shall, at its expense, promptly deliver to the Purchaser a certificate of an officer of the Company setting forth the nature of
such adjustment and showing in detail the facts upon which such adjustment is based. 
 8. REPRESENTATIONS OF PURCHASER. As of the date
hereof, the Purchaser hereby confirms the representations and warranties made by the Purchaser in Section 4 of the Purchase Agreement. 
 9. COMPLIANCE WITH SECURITIES LAWS. 
 (a) The Purchaser understands that this Warrant and the Warrant Stock are characterized as
“restricted securities” under the federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering and that under such laws and applicable regulations this Warrant and the
Warrant Stock may be resold without registration under the Securities Act only in certain limited circumstances. In this connection, the Purchaser represents that it is familiar with Rule 144 under the Securities Act of 1933, as amended (the
“Securities Act”), as presently in effect, and understands the resale limitations imposed thereby and by the Securities Act. 
 (b) Prior and as a condition to any exercise of this Warrant (unless the Purchaser has elected the Net Exercise Right) or the sale or transfer of the Warrant Stock issuable upon exercise of this Warrant, the Purchaser shall furnish to the
Company such certificates, representations, agreements and other information, including an opinion of counsel, as the Company or the Company’s transfer agent reasonably may require to confirm that such exercise, sale or transfer is being made
pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act unless such Warrant Stock is being sold or transferred pursuant to an effective registration statement. 
  

 -4- 

 (c) The Purchaser acknowledges that the Company may place a restrictive legend on the Warrant Stock
issuable upon exercise of this Warrant in order to comply with securities laws unless such shares of Warrant Stock are otherwise freely tradable under Rule 144 of the Securities Act. 
 10. NOTICES OF RECORD DATE. In the event of: 
 (a) any taking by the Company of a record of the holders of any class of securities for the purpose of determining the holders thereof who are entitled to receive any dividend (other than a cash dividend payable out of earned surplus of the
Company) or other distribution, or any right to subscribe for, purchase or otherwise acquire any shares of stock of any class or any other securities or property, or to receive any other right; or 
 (b) any Reorganization or Merger; or 
 (c)
any voluntary or involuntary dissolution, liquidation or winding-up of the Company, then and in each such event the Company will mail or cause to be delivered to the Purchaser (or a permitted transferee in compliance with Section 9 above) a
notice specifying (i) the date on which any such record is to be taken for the purpose of such dividend, distribution or right, and stating the amount and character of such dividend, distribution or right, and (ii) the date on which any
such Reorganization, Merger, dissolution, liquidation or winding-up is to take place, and the time, if any, as of which the holders of record of Common Stock (or other securities) shall be entitled to exchange their shares of Common Stock (or other
securities) for securities or other property deliverable upon such Reorganization, Merger, dissolution, liquidation or winding-up. Such notice shall be delivered at least ten (10) business days prior to the date therein specified. 

11. REPLACEMENT OF WARRANTS. On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this
Warrant and, in the case of any such loss, theft, destruction or mutilation of this Warrant, on delivery of an indemnity agreement or security reasonably satisfactory in form and amount to the Company or, in the case of any such mutilation, on
surrender and cancellation of such Warrant, the Company at its expense will execute and deliver, in lieu thereof, a new Warrant of like tenor. 
 12. NO IMPAIRMENT. Except to the extent as may be waived by the holder of this Warrant, the Company will not, by amendment of its charter or through a Reorganization, Merger, dissolution, sale of assets or any other voluntary action, avoid
or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such action as may be necessary or appropriate in order to
protect the rights of the Purchaser against impairment. 
 13. SATURDAYS, SUNDAYS, HOLIDAYS, ETC. If the last or appointed day for the taking
of any action or the expiration of any right required or granted herein shall be a Saturday or Sunday or shall be a legal U.S. holiday, then such action may be taken or such right may be exercised on the next succeeding day not a Saturday, Sunday or
legal U.S. holiday. 
  

 -5- 

 14. TRANSFERS; EXCHANGES. (a) Subject to compliance with applicable federal and state securities
laws and Section 9 hereof, this Warrant may be transferred by the Purchaser with respect to any or all of the Warrant Stock purchasable hereunder. Upon surrender of this Warrant to the Company, together with the Notice of Assignment in the form
attached hereto as Exhibit B duly completed and executed on behalf of the Purchaser, for transfer of this Warrant as an entirety by Purchaser, the Company shall issue a new Warrant of the same denomination to the assignee. Upon surrender of
this Warrant to the Company, together with the Notice of Assignment in the form attached hereto as Exhibit B duly completed and executed on behalf of the Purchaser, for transfer of this Warrant with respect to a portion of the Warrant Stock
purchasable hereunder, the Company shall issue a new Warrant to the assignee, in such denomination as shall be requested by the Purchaser, and shall issue to the Purchaser a new Warrant covering the number of shares in respect of which this Warrant
shall not have been transferred. 
 (b) This Warrant is exchangeable, without expense, at the option of the Holder, upon presentation and
surrender hereof to the Company for other warrants of different denominations entitling the holder thereof to purchase in the aggregate the same number of shares of Common Stock purchasable hereunder. This Warrant may be divided or combined with
other warrants that carry the same rights upon presentation hereof at the principal office of the Company together with a written notice specifying the denominations in which new warrants are to be issued to the Holder and signed by the Holder
hereof. The term “Warrants” as used herein includes any warrants into which this Warrant may be divided or exchanged. 
 15.
MISCELLANEOUS. This Agreement shall be governed by and construed in accordance with the internal laws of the State of New York. All notices, requests, consents and other communications hereunder shall be in writing, shall be sent by confirmed
facsimile or electronic mail, or mailed by first-class registered or certified airmail, or nationally recognized overnight express courier, postage prepaid, and shall be deemed given when so sent in the case of facsimile or electronic mail
transmission, or when so received in the case of mail or courier, and addressed as follows: (a) if to the Company, at 149 Commonwealth Drive, Menlo Park, California 94025, Attention: Chief Executive Officer; Facsimile: (650) 327-3218;
E-Mail: [            ]@corcept.com; with a copy to Latham & Watkins LLP, 140 Scott Drive, Menlo Park, California 94025, Attention: Alan C. Mendelson; Facsimile:
(650) 463-4693; E-Mail: alan.mendelson@lw.com and (b) if to the Purchaser, at such address or addresses as may have been furnished by the Purchaser to the Company in writing. The invalidity or unenforceability of any provision hereof shall
in no way affect the validity or enforceability of any other provisions. 
 16. WAIVER. The Company will not, by any voluntary action avoid
or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder by the Company, but will at all times in good faith assist in the carrying out of all provisions of this Warrant and in the taking of all such
action as may be necessary or appropriate in order to protect the rights of the Holder of this Warrant against impairment. 
  

 -6- 

 17. OPTIONAL REDEMPTION. Provided that the shares
of Warrant Stock are registered on an effective registration statement (other than due to the lapse of the Effectiveness Period (as defined in the Registration Rights Agreement dated March 14, 2008 by and among the Company and the investors
named therein (the “Registration Rights Agreement”))) or are otherwise freely tradable under Rule 144(b)(i) without volume limitation, at any time after the occurrence of a Redemption Condition (as defined below), the Company shall
be entitled to redeem the Warrants, or any of them, for no consideration, upon 30 days’ written notice to the Purchaser. Hereinafter, such 30-day period, as it may be extended pursuant to this Section 17, is referred to as the
“Redemption Period”. Upon the expiration of the Redemption Period (the “Redemption Date”), all Warrants noticed for redemption that have not theretofore been exercised by the Purchaser shall cease to represent the
right to purchase any shares of Warrant Stock and shall be deemed cancelled and void and of no further force or effect without any further act or deed on the part of the Company. The Purchaser undertakes to return the certificate representing any
redeemed Warrants to the Company upon their redemption. In the event the certificate so returned represents a number of Warrants in excess of the number being redeemed, the Company shall as promptly as practicable issue to the Purchaser a new
certificate for the number of unredeemed Warrants. If at any time during the Redemption Period but until the earlier of (i) the expiration of the Effectiveness Period (as defined in the Registration Rights Agreement) and (ii) the time at
which the Warrant Shares are freely tradable under Rule 144(b)(i) without volume limitation, the prospectus used in connection with the disposition of the shares of Warrant Stock pursuant to a Registration Statement (as defined in the Purchase
Agreement) may not be used by the Purchaser for the resale of the shares of Warrant Stock, then the Redemption Period shall be extended by the period of time that the Purchaser may not so use the prospectus. For purposes of this section, a
“Redemption Condition” shall have occurred if, at any time prior to March 25, 2010, the Fair Market Value of a share of Common Stock is greater than 300% of the Warrant Price then in effect for 20 consecutive trading days. The
Redemption Condition shall be deemed to be satisfied on such 20th consecutive trading day. 
 [Signature Page Follows] 
  

 -7- 

 IN WITNESS WHEREOF, this Common Stock Purchase Warrant is issued effective as of the date first set forth
above. 
  

			
	CORCEPT THERAPEUTICS INCORPORATED
		
	By:	 	  

	Name:	 	
	Title:	 	

  

 Signature Page to Warrant 

 EXHIBIT A 
 NOTICE OF INTENT TO EXERCISE 
 (To be signed only upon exercise of Warrant) 
 To: Corcept Therapeutics Incorporated 
 The undersigned, the
Purchaser of the attached Warrant, hereby irrevocably elects to exercise the purchase right represented by such Warrant for, and to purchase thereunder,
                     (            ) shares of Common Stock of Corcept
Therapeutics Incorporated and (choose one) 
                      herewith makes payment of
                     Dollars ($
                    ) thereof 
 or 
                      exercises the Net Exercise Right pursuant to Section 1(b) thereof and requests that the certificates for
such shares be issued in the name of, and delivered to  
                                       
  , whose address is 
  

	
	  
 

                                       
                                  . 
 The undersigned by its signature below it hereby represents and warrants that it is an “accredited investor” as defined in Rule 501(a) of
Regulation D promulgated under the Securities Act of 1933, as amended, and agrees to be bound by the terms and conditions of the attached Warrant as of the date hereof, including Section 9 thereof. 
  

			
	DATED:	 	  

  

			
	 (Signature must conform in all
 respects to
name of the Purchaser as specified on the face of the Warrant)

	
	  

	  

	
	(Address)

 EXHIBIT B 
 NOTICE OF ASSIGNMENT FORM 
 FOR VALUE RECEIVED,
                                        
(the “Assignor”) hereby sells, assigns and transfers all of the rights of the undersigned Assignor under the attached Warrant with respect to the number of shares of common stock of Corcept Therapeutics Incorporated (the
“Company”) covered thereby set forth below, to the following “Assignee” and, in connection with such transfer, represents and warrants to the Company that the transfer is in compliance with Section 9 of the
Warrant and applicable federal and state securities laws: 
  

									
	NAME OF ASSIGNEE	 		 		 	ADDRESS/FAX NUMBER
					
	Dated:	 	  
	 		 	Signature:	 	  

					
		 		 		 	Witness:	 	  

 ASSIGNEE ACKNOWLEDGMENT 
 The undersigned Assignee acknowledges that it has reviewed the attached Warrant and by its signature below it hereby represents and warrants that it is
an “accredited investor” as defined in Rule 501(a) of Regulation D promulgated under the Securities Act of 1933, as amended, and agrees to be bound by the terms and conditions of the attached Warrant as of the date hereof, including
Section 9 thereof. 
  

					
	Signature:	 	  

		
	By:	 	  

	Its:	 	  

 Address:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00139-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00139-of-00352.parquet"}]]